Titre : Hypertension rénovasculaire

Hypertension rénovasculaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Mass Screening
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypertension rénovasculaire : Questions médicales les plus fréquentes", "headline": "Hypertension rénovasculaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypertension rénovasculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-30", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypertension rénovasculaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hypertension rénale", "url": "https://questionsmedicales.fr/mesh/D006977", "about": { "@type": "MedicalCondition", "name": "Hypertension rénale", "code": { "@type": "MedicalCode", "code": "D006977", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.489.631" } } }, "about": { "@type": "MedicalCondition", "name": "Hypertension rénovasculaire", "alternateName": "Hypertension, Renovascular", "code": { "@type": "MedicalCode", "code": "D006978", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Eduardo Colombari", "url": "https://questionsmedicales.fr/author/Eduardo%20Colombari", "affiliation": { "@type": "Organization", "name": "From the Department of Physiology and Pathology, School of Dentistry of Araraquara, São Paulo State University, Araraquara, Brazil (M.V.F.S., M.R.M., G.M.L., M.R.L., G.F., J.V.M., D.S.A.C., E.C.)." } }, { "@type": "Person", "name": "Kjell Tullus", "url": "https://questionsmedicales.fr/author/Kjell%20Tullus", "affiliation": { "@type": "Organization", "name": "Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust." } }, { "@type": "Person", "name": "Mariana Rosso Melo", "url": "https://questionsmedicales.fr/author/Mariana%20Rosso%20Melo", "affiliation": { "@type": "Organization", "name": "From the Department of Physiology and Pathology, School of Dentistry of Araraquara, São Paulo State University, Araraquara, Brazil (M.V.F.S., M.R.M., G.M.L., M.R.L., G.F., J.V.M., D.S.A.C., E.C.)." } }, { "@type": "Person", "name": "Jose V Menani", "url": "https://questionsmedicales.fr/author/Jose%20V%20Menani", "affiliation": { "@type": "Organization", "name": "From the Department of Physiology and Pathology, School of Dentistry of Araraquara, São Paulo State University, Araraquara, Brazil (M.V.F.S., M.R.M., G.M.L., M.R.L., G.F., J.V.M., D.S.A.C., E.C.)." } }, { "@type": "Person", "name": "Mariana R Lauar", "url": "https://questionsmedicales.fr/author/Mariana%20R%20Lauar", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pathology, School of Dentistry, São Paulo State University, UNESP, Araraquara, SP, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Overestimation of screening-related complications in the National Lung Screening Trial.", "datePublished": "2022-11-14", "url": "https://questionsmedicales.fr/article/36503729", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jtcvs.2022.10.051" } }, { "@type": "ScholarlyArticle", "name": "Durability of FIT Screening After Cessation of a Screening Outreach Intervention.", "datePublished": "2022-11-10", "url": "https://questionsmedicales.fr/article/36357595", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10620-022-07755-7" } }, { "@type": "ScholarlyArticle", "name": "Colorectal cancer screening: understanding the needs of the pre-screening group.", "datePublished": "2023-03-28", "url": "https://questionsmedicales.fr/article/36976250", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.21101/cejph.a7184" } }, { "@type": "ScholarlyArticle", "name": "Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36436778", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jacr.2022.11.005" } }, { "@type": "ScholarlyArticle", "name": "Screening is not always healthy: an ethical analysis of health screening packages in Singapore.", "datePublished": "2022-06-07", "url": "https://questionsmedicales.fr/article/35672820", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12910-022-00798-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Hypertension artérielle", "item": "https://questionsmedicales.fr/mesh/D006973" }, { "@type": "ListItem", "position": 5, "name": "Hypertension rénale", "item": "https://questionsmedicales.fr/mesh/D006977" }, { "@type": "ListItem", "position": 6, "name": "Hypertension rénovasculaire", "item": "https://questionsmedicales.fr/mesh/D006978" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypertension rénovasculaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypertension rénovasculaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypertension rénovasculaire", "description": "Comment diagnostiquer l'hypertension rénovasculaire ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent une hypertension rénovasculaire ?\nQuel rôle joue l'angiographie dans le diagnostic ?\nPeut-on utiliser des tests sanguins pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Mass+Screening&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypertension rénovasculaire", "description": "Quels sont les symptômes de l'hypertension rénovasculaire ?\nL'hypertension rénovasculaire cause-t-elle des douleurs ?\nComment l'hypertension rénovasculaire affecte-t-elle la santé ?\nY a-t-il des symptômes spécifiques chez les jeunes ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Mass+Screening&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypertension rénovasculaire", "description": "Comment prévenir l'hypertension rénovasculaire ?\nQuel rôle joue l'alimentation dans la prévention ?\nL'exercice physique aide-t-il à prévenir cette condition ?\nFumer influence-t-il l'hypertension rénovasculaire ?\nLe stress a-t-il un impact sur l'hypertension ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Mass+Screening&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypertension rénovasculaire", "description": "Quels traitements sont disponibles pour l'hypertension rénovasculaire ?\nQuand la chirurgie est-elle nécessaire ?\nQuels médicaments sont couramment prescrits ?\nComment surveiller l'efficacité du traitement ?\nY a-t-il des effets secondaires aux traitements ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Mass+Screening&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypertension rénovasculaire", "description": "Quelles sont les complications de l'hypertension rénovasculaire ?\nComment l'hypertension rénovasculaire affecte-t-elle les reins ?\nY a-t-il un risque accru d'AVC ?\nQuels sont les effets sur le cœur ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Mass+Screening&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypertension rénovasculaire", "description": "Quels sont les principaux facteurs de risque ?\nLe diabète influence-t-il l'hypertension rénovasculaire ?\nL'hérédité joue-t-elle un rôle ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006978?mesh_terms=Mass+Screening&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hypertension rénovasculaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique, l'imagerie et des tests de fonction rénale." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'échographie Doppler, l'IRM et l'angiographie." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une hypertension rénovasculaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une hypertension résistante aux traitements et des anomalies rénales peuvent indiquer cette condition." } }, { "@type": "Question", "name": "Quel rôle joue l'angiographie dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'angiographie permet de visualiser les artères rénales et d'identifier les rétrécissements." } }, { "@type": "Question", "name": "Peut-on utiliser des tests sanguins pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent évaluer la fonction rénale et détecter des anomalies." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hypertension rénovasculaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles de la vision." } }, { "@type": "Question", "name": "L'hypertension rénovasculaire cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des douleurs abdominales ou lombaires en raison de l'ischémie rénale." } }, { "@type": "Question", "name": "Comment l'hypertension rénovasculaire affecte-t-elle la santé ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des complications cardiovasculaires et rénales graves si non traitée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les jeunes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes peuvent présenter une hypertension sévère sans antécédents familiaux." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus aigus chez les jeunes et plus insidieux chez les âgés." } }, { "@type": "Question", "name": "Comment prévenir l'hypertension rénovasculaire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain, contrôler le poids et surveiller la pression artérielle." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, pauvre en sel et riche en potassium, aide à prévenir l'hypertension." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir cette condition ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier contribue à maintenir une pression artérielle normale." } }, { "@type": "Question", "name": "Fumer influence-t-il l'hypertension rénovasculaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme aggrave les problèmes vasculaires et augmente le risque d'hypertension." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur l'hypertension ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'élévation de la pression artérielle." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'hypertension rénovasculaire ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments antihypertenseurs et des interventions chirurgicales." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée en cas de rétrécissement sévère ou de résistance au traitement médical." } }, { "@type": "Question", "name": "Quels médicaments sont couramment prescrits ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les inhibiteurs de l'ECA, les bloqueurs des récepteurs de l'angiotensine et les diurétiques." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La pression artérielle et la fonction rénale doivent être régulièrement surveillées." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les effets secondaires peuvent inclure des hypotensions, des vertiges et des troubles électrolytiques." } }, { "@type": "Question", "name": "Quelles sont les complications de l'hypertension rénovasculaire ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance rénale, les AVC et les maladies cardiaques." } }, { "@type": "Question", "name": "Comment l'hypertension rénovasculaire affecte-t-elle les reins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une ischémie rénale, entraînant une insuffisance rénale chronique." } }, { "@type": "Question", "name": "Y a-t-il un risque accru d'AVC ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hypertension rénovasculaire augmente le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Quels sont les effets sur le cœur ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une hypertrophie cardiaque et des maladies coronariennes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié et précoce." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'hypertension antérieure, le tabagisme et le diabète." } }, { "@type": "Question", "name": "Le diabète influence-t-il l'hypertension rénovasculaire ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète augmente le risque de maladies vasculaires et d'hypertension rénovasculaire." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'hypertension augmentent le risque de développer cette condition." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire contribue à l'obésité et à l'hypertension." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'élévation de la pression artérielle." } } ] } ] }

Sources (10000 au total)

Overestimation of screening-related complications in the National Lung Screening Trial.

Lung cancer screening-associated complications are often quoted as one of the major barriers for wider screening adoption. A detailed analysis of the National Lung Screening Trial dataset was performe... Lung cancer screening-associated invasive procedures and their related complications were analyzed using the National Lung Screening Trial dataset. Factors associated with 90-day postprocedure complic... Major complications rate in patients undergoing low-dose computed tomography screening who were diagnosed with lung cancer was 10.2% compared with only 0.04% for patients without lung cancer. Low-dose... It is more informative to report procedural complications in patients not found to have cancer as the true screening-associated risk. Only 4 in 10,000 of patients undergoing low-dose computed tomograp...

Durability of FIT Screening After Cessation of a Screening Outreach Intervention.

Organized outreach to increase CRC screening using mailed FIT tests has been shown to be effective, but durable changes to screening behavior after cessation of screening is not known.... In this study, after cessation of funding for an organized cancer screening outreach program, we evaluated whether adherence to screening remained elevated. Patients aged 50-75 years eligible for CRC ... Despite higher rates of FIT screening for patients who were randomly assigned to the outreach intervention, FIT completion was not significantly different between the group that received the outreach ... Outreach campaigns and their activities must be sustained to maintain improved rates of screening participation....

Colorectal cancer screening: understanding the needs of the pre-screening group.

For the last three decades, although colorectal cancer incidence has been decreasing in those over 50 years of age, it has been increasing in those under 50 included in the pre-screening group (PSG). ... This cross-sectional study was conducted with a total of 323 participants, 143 of whom were from the pre-screening group (40-49 years), and 180 from the screening included group (SIG) (50-70 years).... Individuals included in PSG were more likely to have accepted that both faecal occult blood test (FOBT) (2.23 ± 1.22 vs. 1.89 ± 1.33, p = 0.018) and colonoscopy (2.37 ± 0.97 vs. 2.02 ± 1.14, p = 0.003... The findings show that PSG has different characteristics than SIG and may be more fitting in the colorectal cancer screening programme if included....

Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough.

Adherence to lung cancer screening (LCS) is central to effective screening. The authors evaluated the likelihood of repeat annual LCS in a national commercially insured population and associations wit... Using claims data from an employer-insured population (Clinformatics), individuals 55 to 80 years of age undergoing LCS between January 1, 2015, to September 30, 2019, with "negative" LCS were include... Of 14,943 individuals with negative LCS, 4,561 (30.5%) underwent repeat LCS. Likelihood of repeat LCS was decreased for men (adjusted odds ratio [aOR], 0.91; 95% confidence interval [CI], 0.86-0.97), ... Although federal policies facilitate LCS without cost sharing, individuals incurring high OOPC, even when unrelated to LCS, are less likely to undergo repeat LCS. Future policy design should consider ...

Screening is not always healthy: an ethical analysis of health screening packages in Singapore.

Health screening is undertaken to identify individuals who are deemed at higher risk of disease for further diagnostic testing so that they may possibly benefit from interventions to modify the natura... A content analysis of the websites of providers offering general health screening packages to individuals was conducted. A total of 14 health screening package providers were analysed for how packages... Twelve of the 14 providers included non-recommended tests such as tumour markers, treadmill stress tests and MRI scans in their general health screening packages. Package prices ranged from S$26 to S$... Several ethical issues were identified that should be addressed with regard to health screening packages in Singapore. A key issue was the information gap between providers and patients, which may res...

Screening of dysphagia in geriatrics.

The oropharyngeal dysphagia is an underestimated symptom with various causes in the geriatric population. Clinical presentation is often insidious and dysphagia symptoms are seldomly mentioned by elde... A sample of 200 Egyptian Arabic-speaking elderly patients (65 years or older) not complaining of dysphagia was recruited from nursing homes in Greater Cairo Area. They or their caregivers completed th... The dysphagia manifestations questionnaire was significantly correlated with EAT 10 with p value of 0.001. It was correlated in some of its aspects with FEES showing quite reliability with p values' r... the use of this easy applicable screening tool managed to suspect and later on diagnose cases with oropharyngeal dysphagia in non-complaining aging subjects....